ArticleEBioMedicine2019
Gastrointestinal AEs seen in the POP trial due to SOD mimetic activity of calmangafodipir? - Authors' reply.
James W DearPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
1 paper cites it
this papercites it
ArticleEBioMedicine2019
James W DearPubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.